Sionna Therapeutics (NASDAQ:SION) Shares Gap Down – Time to Sell?

Sionna Therapeutics, Inc. (NASDAQ:SION)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $10.00, but opened at $9.68. Sionna Therapeutics shares last traded at $11.35, with a volume of 122,379 shares.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on SION. Stifel Nicolaus assumed coverage on shares of Sionna Therapeutics in a report on Tuesday, March 4th. They issued a “buy” rating and a $32.00 price target for the company. Guggenheim assumed coverage on shares of Sionna Therapeutics in a research note on Tuesday, March 4th. They set a “buy” rating and a $45.00 target price for the company. Finally, TD Cowen began coverage on shares of Sionna Therapeutics in a research report on Tuesday, March 4th. They issued a “buy” rating on the stock.

Sionna Therapeutics Stock Up 11.9 %

The stock has a fifty day moving average price of $13.17.

Sionna Therapeutics (NASDAQ:SION) last released its quarterly earnings results on Thursday, March 20th. The company reported ($3.38) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.68) by ($0.70).

About Sionna Therapeutics

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.